- Avanos Medical press release (NYSE:AVNS): Q2 Non-GAAP EPS of $0.17 beats by $0.02.
- Revenue of $175M (+1.9% Y/Y) beats by $9.5M.
- For the three months ended June 30, 2025, net sales totaled $175.0 million, an increase of 1.9% compared to the prior year period, due to